Major trial to test multiple drugs for progressive supranuclear palsy

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

Opinion | The Dreaded Cocktail Party Conversation

Fred Pelzman of Weill Cornell Internal Medicine Associates and weekly blogger for MedPage Today, follows what’s going on in the world of primary care medicine

August 15, 2023

Medicare for Renal Denervation; Cardiac Telemetry App Recall; Stroke Flags in Eyes

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced. The

January 15, 2025

$750,000 training program grant awarded to support the Industrial Hygiene Program

The National Institute for Occupational Safety and Health, a division of the National Institutes of Health, awarded a $750,000 training program grant to researchers at

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.